Though severe side effects were not found in Ali’s investigation [1] and were not reported previously in adolescents following vaccinations with the mRNA-1273 SARS-CoV-2 vaccine(Moderna), there are several reports of severe adverse reactions to this vaccine in adults.
In a 22yo male with a history of mild COVID-19 6m prior, peri-myocarditis developed 3d after the first dose of the Moderna vaccine [2]. The patient markedly benefited from aspirin and colchicine [2].
A 77yo male developed immune encephalitis, myoclonus, and Sweet-syndrome 1d after the first Moderna dose [3]. He profited significantly from methyl-prednisolone.[3]
A 60yo male with a history of hepatitis-C, renal insufficiency, hypertension, and heart failure, presented with purpuric rash and thrombocytopenia (84000/µL) without major bleeding 2d after the first Moderna dose [4].
A 66yo male developed a large-area, painful blistering rash 1d after the second Moderna dose [5]. He benefited from mupirocin and prednisone.
One day after the second Moderna dose, a 34yo male developed myocarditis. Aspirin, colchicine, bisoprolol and rampiril were beneficial.
Though severe adverse reactions to Moderna are rarely reported, they might be harmful to those experiencing them.
Ali K et al. "Evaluation of mRNA-1273 SARS-CoV-2 vaccine in adolescents." N Engl J Med, 2021, doi: 10.1056/NEJMo a2109522.
Hasnie AA et al. "Perimyocarditis following first dose of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine in a healthy young male: a case report." BMC Cardiovasc Disord, vol. 21, no. 1, 2021, pp. 375, doi: 10.1186/s12872-021-02183-3.
Torrealba-Acosta G et al. "Acute encephalitis, myoclonus and Sweet syndrome after mRNA-1273 vaccine." BMJ Case Rep, vol. 14, no. 7, 2021, e243173, doi: 10.1136/bcr-2021-243173.
Chen PW et al. "Addressing vaccine-induced immune thrombotic thrombocytopenia (VITT) following COVID-19 vaccination: A mini-review of practical strategies." Acta Cardiol Sin, vol. 37, no. 4, 2021, pp. 355-364, doi: 10.6515/ACS.202107_37(4).20210628A.